Lung Cancer Prevention Screening Programme in Italy (RISP)
Lung Cancer, COPD (Chronic Obstructive Pulmonary Disease) With Acute Lower Respiratory Infection, Cardiovascular Diseases
About this trial
This is an interventional prevention trial for Lung Cancer focused on measuring lung cancer, LDCT, cytisine, screening, smoking cessation, DOPC, cardiovascular diseases, primary prevention, secondary prevention, RCT, microRNA, biomarkers
Eligibility Criteria
Inclusion Criteria: Active smoker (≥ 30 packs/year) Former heavy smoker for ≤ 15 years (≥ 30 packs/year) Absence of tumors for at least 5 years Signature of informed consent for studio enrollment and processing of personal data Exclusion Criteria: Severe chronic disease (e.g. severe respiratory and/or renal and/or hepatic and/or cardiac failure) Severe psychiatric problems Abuse of alcohol or other substances (including previous)
Sites / Locations
- Chiara BovolentaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Standard arm
Risk-based arm
Volunteers with a negative baseline LDCT will repeat LDCT after the first screening with an annual interval (according to guidelines)
Volunteers with a negative baseline LDCT will repeat LDCT after the first screening with an interval of two years.